PhytoHealth Corporation (TPE:4108)

Market Cap	2.74B
Revenue (ttm)	138.46M
Net Income (ttm)	-59.76M
Shares Out	198.62M
EPS (ttm)	-0.30
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	257,607
Average Volume	164,565
Open	13.90
Previous Close	13.80
Day's Range	13.65 - 13.90
52-Week Range	11.00 - 17.90
Beta	0.36
RSI	49.07
Earnings Date	Feb 24, 2026

About PhytoHealth

PhytoHealth Corporation researches, develops, manufactures, and sells medicines, cosmetics, Class B medicines, complementary foods, and other related products in Taiwan. It operates in three segments: Medicines and Health Food, Medical Diagnosis, and Precision Medical Equipment and Instruments. The Medicines and Health Food segment manufactures and sells Chinese medicine materials and new drugs. The Medical Diagnosis segment develops and sells smart medical imaging diagnostic products. The Precision Medical Equipment and Instruments segment eng...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 84
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 4108

Financial Performance

In 2024, PhytoHealth's revenue was 153.56 million, a decrease of -5.49% compared to the previous year's 162.49 million. Losses were -73.50 million, 56.0% more than in 2023.